A similar analysis of lymphoid cells at 21 days after CT2A tumor implantation revealed no difference in numbers of NK cells, NKT cells, or Tregs but an increase in numbers of CD4+ T cells (~4.2-fold) (Figure 2D). This evidence concerns the gene CD4 and neoplasm.